1. Home
  2. SCLX vs BIOX Comparison

SCLX vs BIOX Comparison

Compare SCLX & BIOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

N/A

Current Price

$2.06

Market Cap

27.9M

Sector

Health Care

ML Signal

N/A

Logo Bioceres Crop Solutions Corp.

BIOX

Bioceres Crop Solutions Corp.

N/A

Current Price

$0.23

Market Cap

23.7M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
SCLX
BIOX
Founded
2011
2001
Country
United States
Argentina
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Agricultural Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
27.9M
23.7M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
SCLX
BIOX
Price
$2.06
$0.23
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
40.4K
★ 163.9K
Earning Date
11-13-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $30,253,000.00
N/A
Revenue This Year
$118.16
$59.25
Revenue Next Year
$186.31
$34.94
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.27
$0.19
52 Week High
$27.00
$2.10

Technical Indicators

Market Signals
Indicator
SCLX
BIOX
Relative Strength Index (RSI) 14.46 27.66
Support Level N/A N/A
Resistance Level $7.77 $0.55
Average True Range (ATR) 0.23 0.03
MACD -0.01 -0.01
Stochastic Oscillator 2.53 23.88

Price Performance

Historical Comparison
SCLX
BIOX

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

About BIOX Bioceres Crop Solutions Corp.

Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

Share on Social Networks: